Michael Lane sold $2.7M of IDEXX Laboratories (IDXX)

Executed Nov 4, disclosed Nov 5, 1 day later.

Value, as filed

$2.7M

3,979 sh across 3 lots

Executed

Nov 4

the trade date, as filed

Disclosed

Nov 5

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Michael Lane Executive Vice President profile →

Michael Lane (Executive Vice President) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in IDEXX Laboratories, Inc. (IDXX). The largest single filing was $2.7M of IDXX (3,979 sh across 3 lots, as filed), executed Nov 4.

The name

IDXX

IDEXX Laboratories, Inc. IDXX · Healthcare · 39 filings in 24 months ticker →

Healthcare · IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Michael Lane in IDXX

IDXXSALE IDEXX Laboratories, Inc. $5.3M
8,411 sh across 3 lots
Exec Aug 6 2025
Filed Aug 8 2025 · 5:30 PM ET